01 September 2018 : Laboratory Research
[Retracted] Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
DOI: 10.12659/MSM.909745
Med Sci Monit 2018; 24: LBR6093-6101
HTML version available soon